Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study

Sikkema, M, Looman, C W N, Steyerberg, E W, Kerkhof, M, Kastelein, F, van Dekken, H, van Vuuren, A J, Bode, W A, van der Valk, H, Ouwendijk, R J T, Giard, R, Lesterhuis, W, Heinhuis, R, Klinkenberg, E C, Meijer, G A, Borg, ter F, Arends, J W, Kolkman, J J, van Baarlen, J, de Vries, R A, Mulder, A H, van Tilburg, A J P, Offerhaus, G J A, ten Kate, F J W, Kusters, J G, Kuipers, E J, Siersema, P D · 2011 · American Journal of Gastroenterology

Abstract

OBJECTIVES: Patients with Barrett's esophagus (BE) have an increased risk of developing esophageal adenocarcinoma (EAC). As the absolute risk remains low, there is a need for predictors of neoplastic progression to tailor more individualized surveillance programs. The aim of this study was to identify such predictors of progression to high-grade dysplasia (HGD) and EAC in patients with BE after 4 years of surveillance and to develop a prediction model based on these factors. METHODS: We included 713 patients with BE (≥ 2 cm) with no dysplasia (ND) or low-grade dysplasia (LGD) in a multicenter, prospective cohort study. Data on age, gender, body mass index (BMI), reflux symptoms, tobacco and alcohol use, medication use, upper gastrointestinal (GI) endoscopy findings, and histology were prospectively collected. As part of this study, patients with ND underwent surveillance every 2 years, whereas those with LGD were followed on a yearly basis. Log linear regression analysis was performed to identify risk factors associated with the development of HGD or EAC during surveillance. RESULTS: After 4 years of follow-up, 26/713 (3.4%) patients developed HGD or EAC, with the remaining 687 patients remaining stable with ND or LGD. Multivariable analysis showed that a known duration of BE of ≥ 10 years (risk ratio (RR) 3.2; 95% confidence interval (CI) 1.3-7.8), length of BE (RR 1.11 per cm increase in length; 95% CI 1.01-1.2), esophagitis (RR 3.5; 95% CI 1.3-9.5), and LGD (RR 9.7; 95% CI 4.4-21.5) were significant predictors of progression to HGD or EAC. In a prediction model, we found that the annual risk of developing HGD or EAC in BE varied between 0.3% and up to 40%. Patients with ND and no other risk factors had the lowest risk of developing HGD or EAC (<1%), whereas those with LGD and at least one other risk factor had the highest risk of neoplastic progression (18-40%). CONCLUSIONS: In patients with BE, the risk of developing HGD or EAC is predominantly determined by the presence of LGD, a known duration of BE of ≥10 years, longer length of BE, and presence of esophagitis. One or combinations of these risk factors are able to identify patients with a low or high risk of neoplastic progression and could therefore be used to individualize surveillance intervals in BE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ajg.2011.153

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 173

Metadata

Authors
Sikkema, M., Looman, C. W. N., Steyerberg, E. W., Kerkhof, M., Kastelein, F., van Dekken, H., van Vuuren, A. J., Bode, W. A., van der Valk, H., Ouwendijk, R. J. T., Giard, R., Lesterhuis, W., Heinhuis, R., Klinkenberg, E. C., Meijer, G. A., Borg, T. F., Arends, J. W., Kolkman, J. J., van Baarlen, J., de Vries, R. A., Mulder, A. H., van Tilburg, A. J. P., Offerhaus, G. J. A., ten Kate, F. J. W., Kusters, J. G., Kuipers, E. J., & Siersema, P. D.
Venue
American Journal of Gastroenterology
Published
2011-07
Volume
106
Issue
7
Pages
1231-1238
ISSN
0002-9270 (ISSN-L)
OpenAlex
W1990046058
Cited by
173
References
1
FWCI
20.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study. https://app.cochat.ai/papers/10.1038/ajg.2011.153
The paper
Sikkema, M., Looman, C. W. N., Steyerberg, E. W., Kerkhof, M., Kastelein, F., van Dekken, H., van Vuuren, A. J., Bode, W. A., van der Valk, H., Ouwendijk, R. J. T., Giard, R., Lesterhuis, W., Heinhuis, R., Klinkenberg, E. C., Meijer, G. A., Borg, T. F., Arends, J. W., Kolkman, J. J., van Baarlen, J., . . . Siersema, P. D. (2011). Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study. American Journal of Gastroenterology. https://doi.org/10.1038/ajg.2011.153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.